Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment

[1]  A. Mira,et al.  Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers , 2015, Journal of Gastroenterology.

[2]  K. Kinzler,et al.  Microbiota organization is a distinct feature of proximal colorectal cancers , 2014, Proceedings of the National Academy of Sciences.

[3]  Jens Roat Kultima,et al.  Potential of fecal microbiota for early‐stage detection of colorectal cancer , 2014 .

[4]  P. Schloss,et al.  The Human Gut Microbiome as a Screening Tool for Colorectal Cancer , 2014, Cancer Prevention Research.

[5]  S. Prakash,et al.  Emerging science of the human microbiome , 2014, Gut microbes.

[6]  Alberto Martin,et al.  The multifaceted role of the intestinal microbiota in colon cancer. , 2014, Molecular cell.

[7]  M. Toyota,et al.  Fusobacterium in colonic flora and molecular features of colorectal carcinoma. , 2014, Cancer research.

[8]  Lawrence A. David,et al.  Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.

[9]  Susumu Goto,et al.  Data, information, knowledge and principle: back to metabolism in KEGG , 2013, Nucleic Acids Res..

[10]  J. Goedert,et al.  Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.

[11]  Emmanuel Buc,et al.  Colonization of the Human Gut by E. coli and Colorectal Cancer Risk , 2013, Clinical Cancer Research.

[12]  E. Kuipers,et al.  Functional genomic analyses of the gut microbiota for CRC screening , 2013, Nature Reviews Gastroenterology &Hepatology.

[13]  L. T. Angenent,et al.  Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. , 2013, Cell host & microbe.

[14]  Dan Knights,et al.  Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome , 2013, Gut.

[15]  Jesse R. Zaneveld,et al.  Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences , 2013, Nature Biotechnology.

[16]  M. Meyerson,et al.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.

[17]  M. R. Rubinstein,et al.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. , 2013, Cell host & microbe.

[18]  Amy M. Sheflin,et al.  Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults , 2013, PloS one.

[19]  G. Gao,et al.  Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients , 2013, Microbial Ecology.

[20]  Emma Allen-Vercoe,et al.  Co-occurrence of anaerobic bacteria in colorectal carcinomas , 2013, Microbiome.

[21]  Jeffrey J Meyer,et al.  Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012. (5) , 2013 .

[22]  F. Kasuga,et al.  Providencia alcalifaciens causes barrier dysfunction and apoptosis in tissue cell culture: potent role of lipopolysaccharides on diarrheagenicity , 2013, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[23]  Zhigang Zhang,et al.  Diversified pattern of the human colorectal cancer microbiome , 2013, Gut Pathogens.

[24]  N. A. Temiz,et al.  APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.

[25]  H. Tjalsma,et al.  Screening metatranscriptomes for toxin genes as functional drivers of human colorectal cancer. , 2013, Best practice & research. Clinical gastroenterology.

[26]  S. Lok,et al.  Biased Diversity Metrics Revealed by Bacterial 16S Pyrotags Derived from Different Primer Sets , 2013, PloS one.

[27]  Rob Knight,et al.  Advancing our understanding of the human microbiome using QIIME. , 2013, Methods in enzymology.

[28]  D. Kobayashi,et al.  Changes of the Intestinal Microbiota, Short Chain Fatty Acids, and Fecal pH in Patients with Colorectal Cancer , 2013, Digestive Diseases and Sciences.

[29]  B. Lazzaro,et al.  Comparative genomics of bacteria in the genus Providencia isolated from wild Drosophila melanogaster , 2012, BMC Genomics.

[30]  Belgin Dogan,et al.  Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota , 2012, Science.

[31]  Jonathan Friedman,et al.  Inferring Correlation Networks from Genomic Survey Data , 2012, PLoS Comput. Biol..

[32]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[33]  C. Xiang,et al.  Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer , 2012, PloS one.

[34]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[35]  B. Birren,et al.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.

[36]  Richard A. Moore,et al.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.

[37]  S. Yamasaki,et al.  Molecular Characterizations of Cytolethal Distending Toxin Produced by Providencia alcalifaciens Strains Isolated from Patients with Diarrhea , 2012, Infection and Immunity.

[38]  S. Yamasaki,et al.  Prevalence of Providencia strains among children with diarrhea in Japan. , 2012, Japanese journal of infectious diseases.

[39]  N. Hall,et al.  Towards the Human Colorectal Cancer Microbiome , 2011, PloS one.

[40]  Ali Nadim,et al.  Mechanical Disruption of Lysis-Resistant Bacterial Cells by Use of a Miniature, Low-Power, Disposable Device , 2011, Journal of Clinical Microbiology.

[41]  Peer Bork,et al.  Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy , 2011, Nucleic Acids Res..

[42]  J. Tap,et al.  Microbial Dysbiosis in Colorectal Cancer (CRC) Patients , 2011, PloS one.

[43]  R. Sartor,et al.  Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome , 2010, Gut pathogens.

[44]  Robert C. Edgar,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .

[45]  Gary D. Bader,et al.  Cytoscape Web: an interactive web-based network browser , 2010, Bioinform..

[46]  Zaid Abdo,et al.  Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas , 2010, Gut microbes.

[47]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[48]  F. Bushman,et al.  QIIME allows integration and analysis of high-throughput community sequencing data. Nat. Meth. , 2010 .

[49]  Jungmin Kim,et al.  Multidrug-resistant Providencia isolates carrying blaPER-1, blaVIM-2, and armA. , 2007, Journal of microbiology.

[50]  Adam Zemla,et al.  MvirDB—a microbial database of protein toxins, virulence factors and antibiotic resistance genes for bio-defence applications , 2006, Nucleic Acids Res..

[51]  C. Karp,et al.  Ocular infections caused by Providencia rettgeri. , 2006, Ophthalmology.

[52]  G. Rossolini,et al.  Trends in Production of Extended-Spectrum β-Lactamases among Enterobacteria of Medical Interest: Report of the Second Italian Nationwide Survey , 2006, Journal of Clinical Microbiology.

[53]  Eoin L. Brodie,et al.  Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.

[54]  T. Honda,et al.  Importance of Providencia species as a major cause of travellers' diarrhoea. , 2005, Journal of medical microbiology.

[55]  P. Savelkoul,et al.  Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. , 2005, FEMS immunology and medical microbiology.

[56]  M. Peng,et al.  Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection. , 2004, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[57]  K. Tagomori,et al.  A large outbreak of foodborne infection attributed to Providencia alcalifaciens. , 2001, The Journal of infectious diseases.

[58]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[59]  P. Kolenbrander,et al.  Oral microbial communities: biofilms, interactions, and genetic systems. , 2000, Annual review of microbiology.

[60]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[61]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[62]  B. Guth,et al.  Prevalence of invasive ability and other virulence-associated characteristics in Providencia alcalifaciens strains isolated in São Paulo, Brazil. , 1996, Journal of medical microbiology.

[63]  Y. Isshiki,et al.  Extraction and Characterization of the Smooth‐Type Lipopolysaccharide from Fusobacterium nucleatum JCM 8532 and Its Biological Activities , 1996, Microbiology and immunology.

[64]  M. Albert,et al.  Pathogenesis of Providencia alcalifaciens-induced diarrhea , 1992, Infection and immunity.

[65]  T. Miller,et al.  Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer. , 1988, Gut.

[66]  I. Brook,et al.  The relationship between Fusobacterium species and other flora in mixed infection. , 1986, Journal of medical microbiology.

[67]  Baturo Ap,et al.  Etiologic role of bacteria of the genus Providencia in acute intestinal diseases , 1977 .

[68]  A. Baturo,et al.  [Etiologic role of bacteria of the genus Providencia in acute intestinal diseases]. , 1977, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.